Dr. Antoinette J. Wozniak is a medical oncologist and Chief Scientific Officer of the Lung Cancer Research Foundation. Most recently Professor of Medicine in the division of Hematology and Oncology at the University of Pittsburgh, leader of the Lung Cancer Disease Center, and Associate Director for Clinical Research at UPMC Hillman Cancer Center in Pittsburgh,
Dr. Frank V. Fossella is a thoracic medical oncologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. He has been providing expert patient care to patients diagnosed with malignant mesothelioma and lung cancer for almost 50 years and has distinguished himself through research seeking treatment options that deliver improved patient outcomes.
Dr. Misako Nagasaka is an accomplished thoracic oncologist and clinical researcher whose use of novel drug protocols has made a significant difference for her lung cancer and mesothelioma patients, as well as for those diagnosed with thyroid cancer. She practices at the University of California-Irvine in Orange, California. In addition to patient care, Dr. Nagasaka’s
Dr. John Wrangle is a thoracic medical oncologist who specializes in treating non-small cell and small cell lung cancer as well as other thoracic malignancies at the Medical University of South Carolina (MUSC). He is dedicated to bringing novel combination immunotherapy treatments to patient care and has developed precision medicine protocols designed to create additional
Dr. Young Kwang Chae is a medical oncologist and researcher with Northwestern Medicine in Chicago, Illinois, and an Associate Professor of Medicine in the Hematology Oncology Division of the Feinberg School of Medicine. He specializes in treating patients with malignant mesothelioma, lung cancer, breast cancer, and other cancers with a special focus on the use
Dr. Keisuke Shirai is a Professor of Medicine at the Geisel School of Medicine and a medical oncologist at the Dartmouth Hitchcock Norris Cotton Cancer Center. He is a member of both the lung/thoracic cancer program team and the melanoma/skin cancer program team, and his areas of clinical focus are lung cancer, malignant pleural mesothelioma,
Dr. Jhamil Khatri is a hematologist and oncologist at ChristianaCare in Newark, Delaware and its associated Helen F. Graham Cancer Center. He specializes in treating patients diagnosed with lung cancer and other thoracic malignancies, including malignant pleural mesothelioma. He also cares for patients with blood disorders and other cancer diagnoses. As a member of the
Dr. David R. Spigel is a medical oncologist who specializes in treating patients with lung cancer at the Sarah Cannon Research Institute in Nashville, Tennessee. As director of the lung cancer program there, he is actively involved in patient care and developing targeted therapies for the treatment of thoracic malignancies. Dr. Spigel is focused on
Dr. Rachel E. Sanborn is a medical oncologist at the Providence Cancer Institute and co-director of the Providence Thoracic Oncology Program in Portland, Oregon. She treats patients with lung cancers and thoracic malignancies, including malignant pleural mesothelioma. She enjoys the close bond that she forms with her patients and their families, despite the difficult process
Dr. Sameera Kumar is a radiation oncologist and assistant professor in the Department of Radiation Oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania. She specializes in using innovative radiation therapy tools to treat thoracic malignancies including lung cancer, malignant pleural mesothelioma, thymoma, and esophageal cancer. Dr. Kumar works as part of a multidisciplinary care